Loading stock data…
$41.77+0.19 (+0.46%)
Amcor plc, together with its subsidiaries, develops and produces packaging solutions for nutrition, health, beauty, and wellness categories in Europe, North America, Latin America, and the Asia Pacific.
Amcor plc in the Consumer Cyclical sector is trading at $41.77 with a market capitalization of $19.3B. Wall Street consensus targets $49.76 (12 analysts), implying a +19.1% move over the next 12 months. The stock is currently 18% below its 52-week high of $50.94, remaining 0.1% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $6.40B↑ | $5.91B↑ | $5.45B↓ | $5.75B↑ | $5.08B |
| Gross Profit | $1.34B↑ | $1.19B↑ | $1.04B↓ | $1.12B↑ | $895.00M |
| Operating Income | $682.00M↑ | $530.00M↑ | $449.00M↓ | $536.00M↑ | $323.00M |
| Net Income | $389.00M↑ | $278.00M↑ | $177.00M↓ | $262.00M↑ | -$39.00M |
Amcor plc, together with its subsidiaries, develops and produces packaging solutions for nutrition, health, beauty, and wellness categories in Europe, North America, Latin America, and the Asia Pacific. Its products include apparel, applicators, bags...
Academic risk and quality models computed from AMCR's own filings and price history, not from analyst opinion.
Strong on 8 of 9 fundamental-health tests covering profitability, leverage and operating efficiency.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 24.8% reading.
Fama-French 5-factor market beta. The five factors explain 36% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.